Euroapi Appoints Seasoned CFO to Drive Transformative Growth

Euroapi, a leading player in the active pharmaceutical ingredients (API) industry, has announced the appointment of Olivier Falut as its new Chief Financial Officer (CFO), effective October 17, 2024. Falut, a seasoned finance executive with extensive experience in the industrial sector, will join the company's Executive Committee and play a pivotal role in implementing Euroapi's FOCUS-27 transformation project.

Unlocking Euroapi's Potential for Sustainable Growth

Experienced Leadership to Drive Transformation

Olivier Falut brings nearly three decades of expertise in management and finance, having held various financial positions in both listed and non-listed companies across the industrial sector. His impressive track record includes roles at Fareva, Limagrain (including Vilmorin & Cie), Lactalis, and Bel, where he has consistently demonstrated his ability to navigate complex financial landscapes and drive strategic initiatives."I am delighted to welcome Olivier, a seasoned Chief Financial Officer with extensive experience in the industrial sector," said Ludwig de Mot, Euroapi's Chief Executive Officer. "He will play a decisive role in implementing our FOCUS-27 transformation project, and the entire company and the Board of Directors join me in expressing our sincere gratitude to Evelyne for succeeding in her mission to ensure the financing of our strategic plan."

Unlocking Euroapi's Transformative Potential

Falut's appointment comes at a critical juncture for Euroapi, as the company embarks on its FOCUS-27 transformation project. This strategic initiative aims to position Euroapi as a leading player in the active pharmaceutical ingredients market, leveraging its extensive product portfolio, cutting-edge technologies, and robust research and development capabilities."I am excited to be joining Euroapi and to be part of the implementation of the FOCUS-27 transformation plan," said Olivier Falut. "This new economic dynamic will enable us to carry out major projects and to ensure the sustainable growth of the organization for the years to come."

Leveraging Expertise for Sustainable Growth

Falut's extensive experience in the industrial sector, coupled with his proven track record in financial management and strategic planning, positions him as the ideal candidate to spearhead Euroapi's transformation. His expertise will be instrumental in securing the necessary financing, optimizing operational efficiency, and driving the company's long-term growth and profitability.Falut's professional background includes a diverse range of financial roles, from financial audit at Ernst & Young to senior positions at leading industrial companies. His deep understanding of the sector, combined with his strategic vision, will be invaluable in guiding Euroapi through its transformative journey.

Euroapi's Commitment to Sustainable Solutions

Euroapi's focus on reinventing active ingredient solutions to meet the evolving needs of customers and patients aligns with Falut's commitment to driving sustainable growth. The company's dedication to enabling access to essential therapies worldwide, coupled with its strong research and development capabilities and manufacturing expertise, positions it as a key player in the global pharmaceutical industry.As Euroapi embarks on this transformative chapter, the appointment of Olivier Falut as CFO underscores the company's commitment to strengthening its financial foundation and positioning itself for long-term success. With his leadership and expertise, Euroapi is poised to unlock new opportunities, enhance its competitive edge, and deliver innovative solutions that positively impact the lives of patients around the world.